My husband was on immunotherapy for lung cancer which had spread to lymph nodes and pleura. The immunotherapy was stopped as a CT scan showed spread to the liver. He has now been put on Carboplatin and Pemetrexed. After his last (2nd) dose of that his bloods showed an increase in LDH. Stupidly I Googled what this meant and from what I can understand it means his tumour load has increased. I'm scared that this is an indication that the chemo isn't working. Can anyone shed any light on this please?
LDH markers: My husband was on... - The Roy Castle Lu...
LDH markers
Written by
Goingcuckoo
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
RoyCastleHelplinePartnerAsk the NurseRoy Castle
Hello Goingcuckoo,
Blood tests on their own can have many different meanings the best person to discuss them with would be you Lung cancer specialist nurse, she will be able to look at all blood and other test results as a whole interpreting and then be able to explain what they mean, you will also be able to ask her questions.
If you wish to discuss anything you can call us on our nurse led helpline Freephone 0800 358 7200.
Kind regards
The Roy Castle Support Team
Not what you're looking for?
You may also like...
Treatment withdrawn, do we have any more options?
stage IV lung cancer in May 2018. It had spread to his lymph nodes and abdomen. He was given chemo...
Update - Immunotherapy treatment
treatment. His lung mass has shrunk by 20%, and the adrenal gland has remained stable, no further...
Immunotherapy and the 2 year limit
When it spread a few years later and once again Chemo didnt work, the rules around Immunotherapy...
Hope of surviving stage 3b lung cancer NSCLC
centre of her lungs in lymph nodes and on right lung (7cm) and 1cm had spread to left lung. She...
Stage 4 NSCLC with metatasis to brain
me has been diagnosed in April with lung cancer that had spread to the brain. We are in complete...
NSCLC, results of CHART
My latest very sad news
Small cell lung cancer
immunotherapy damaging kidneys 
Immunotherapy what characteristics are required?
